Friday, the FDA approved AstraZeneca Plc (NASDAQ: AZN) and Ionis Pharmaceuticals Inc's (NASDAQ: IONS) Wainua (eplontersen) for polyneuropathy (nerve damage) of hereditary transthyretin-mediated am
Rosenblatt analyst Hans Mosesmann flagged salient articles in the last week specific to AI, Bandwidth, and Computing that are important and merely interesting as they relate to critical secular themes.